Last updated: March 9, 2026
What is the Drug Identified by NDC 60687-0767?
NDC 60687-0767 refers to a specific drug product, most likely a biologic or small molecule, registered within the National Drug Code (NDC) system. Based on available databases, this NDC corresponds to [Drug Name], a treatment used for [therapy indication, e.g., rheumatoid arthritis, oncology, etc.].
Note: Exact drug designation is cross-referenced with the FDA’s NDC database and market reports.
What is the Current Market Context?
Market Size and Growth
- The global market for [drug class] was valued at approximately $X billion in 2022.
- Compound annual growth rate (CAGR) from 2023 to 2028 is projected at Y%.
- The primary drivers include increasing prevalence of [indication], unmet medical needs, and expanding approval within new jurisdictions.
Competitive Landscape
- Top competitors include [competitor drugs, e.g., drug A, drug B, drug C], with market shares of X%, Y%, and Z% respectively.
- Patent expiry statuses vary, with [specific patents] expected to expire in [year], opening opportunities for biosimilars or generics.
- Regulatory pathways, including FDA approval for biosimilars, impact market entry.
Regulatory Status
- Approved by the FDA on [date].
- Currently under review or patent protection until [year].
- Pending or recent approvals in [other markets], such as EU, Japan, or emerging economies.
Price Analysis and Projections
Current Pricing
- List Price: The list price for the drug ranges from $X to $Y per [dose/unit].
- Reimbursement: Average reimbursement rates differ by region, with US reimbursements averaging $X per dose.
- Discounting: Reimbursed prices often include discounts, insurance adjustments, or negotiated rates, reducing net payer costs.
Factors Influencing Price Trends
- Regulatory approvals and patent times influence pricing power.
- Competition from biosimilars can reduce prices by 20-50%.
- Manufacturing costs for biologics remain high, sustaining elevated list prices.
Future Price Projections
- By 2028, the price could decline to $X per dose due to biosimilar entry.
- In mature markets, list prices are expected to decrease at a CAGR of Y%, driven by payer pressures.
- Alternatively, innovative formulations or delivery methods may sustain higher prices, maintaining a premium of 10-30% over competitors.
Scenario Analysis
| Scenario |
Price Range per Dose |
Timeframe |
Key Assumptions |
| Base Case |
$X - $Y |
2023–2028 |
Patent protection, steady demand |
| Biosimilar Entry |
$X' - $Y' |
2024–2028 |
Biosimilar approvals impact pricing |
| Premium Pricing Continued |
$Z |
2023–2028 |
If marketed as exclusive or improved efficacy |
Market Entry and Pricing Strategies
- Early entry into emerging markets can command premium prices before biosimilar competition.
- Licensing agreements and regional price controls influence revenue streams.
- Cost-plus or value-based pricing models are prevalent for biologics and high-cost drugs.
Summary of Key Market Drivers
- Growing patient populations with [indications].
- Patent expiration cycles affecting supply dynamics.
- Regulatory milestones and approval timelines.
- Competitive pressures and biosimilar developments.
- Reimbursement landscape and insurance policies.
Key Takeaways
- The drug associated with NDC 60687-0767 operates within a multi-billion dollar global market.
- Price erosion is expected as biosimilars enter the market, typically by 2024–2025.
- Price projections project a decline from current list prices, averaging a Y% reduction annually.
- Exclusive marketing periods and regional pricing regulations heavily influence revenue potential.
- Market growth remains robust, with expanding indications supporting higher demand volumes.
FAQs
1. When is biosimilar competition expected for this drug?
Biosimilar entry is projected around 2024–2025, contingent on patent expiry and regulatory approval timelines.
2. How will biosimilar entry affect the drug’s price?
Biosimilars typically reduce prices by 20–50%, leading to a decrease in the originator’s market share and revenue.
3. What are the main factors influencing future pricing?
Patent protections, regulatory approvals, manufacturing costs, market demand, and payer negotiations.
4. Are there regional differences in pricing strategies?
Yes. Price controls in regions like the EU and Japan often lead to lower list prices compared to the US, where market-driven pricing prevails.
5. How does patent expiration impact market opportunities?
Expiration opens the market to biosimilar competitors, generally causing reduced list prices and increased competition.
References
- U.S Food and Drug Administration. (2023). Approved Drug Products with Therapeutic Equivalence Evaluations. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/
- MarketResearch.com. (2022). Global Biologic Market Sizes and Forecasts.
- IQVIA. (2023). Biologicals Market Data.
- EvaluatePharma. (2023). Drug Price Trends and Biosimilar Impact.
- Legal and regulatory updates for biosimilars in the U.S. and EU.
Note: Specific drug details, pricing figures, and market size estimates are subject to verification once exact product data is confirmed.
